TP53 and liver cancer: On the other hand, considering that only a few clinical trials have evaluated the long-term efficacy and immunomodulatory effects of rAd-p53, more studies with high-quality evidence are needed to validate the effectiveness of rAd-p53 in the treatment of liver cancer.